
The company plans to unveil a clinically studied ingredient on opening day and host a longevity session alongside its cognitive, mobility, and metabolic health portfolio.
The firm says the relocation will enable it to increase capacity to 500 million effervescent tablets per year.
The Aenova Group, one of Europe’s leading manufacturers of solid oral-dosage forms, says it is relocating its manufacturing operations for effervescent products from Bioggio, Switzerland, to Bad Aibling, Germany. The firm says the relocation will enable it to increase capacity to 500 million effervescent tablets per year.
To accommodate the effervescent manufacturing in May next year, the Bad Aibling site is installing two GMP-compliant production lines.





